EE153 Cost-Effectiveness of First-Line Nivolumab Combination Therapy Vs Chemotherapy Alone for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.456
https://www.valueinhealthjournal.com/article/S1098-3015(23)00556-9/fulltext
Title :
EE153 Cost-Effectiveness of First-Line Nivolumab Combination Therapy Vs Chemotherapy Alone for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00556-9&doi=10.1016/j.jval.2023.03.456
First page :
Section Title :
Open access? :
No
Section Order :
11837